N-Acetylcysteine Supplementation Reduces Oxidative Stress and DNA Damage in Children with β-Thalassemia

References

• Cao A, Galanello R. β-Thalassemia. Genet Med. 2010;12(2):61–76
   PubMed Web of Science ®Google Scholar
• Prati D. Benefits and complications of regular blood transfusion in patients with β-thalassaemia major. Vox Sang. 2000;79(3):129–137
   PubMed Web of Science ®Google Scholar
• Hershko C. Pathogenesis and management of iron toxicity in thalassemia. Ann N Y Acad Sci. 2010;1202:1–9
   PubMed Web of Science ®Google Scholar
• Zastawny TH, Altman SA, Randers-Eichhom L, et al. DNA base modifications and membrane damage in cultured mammalian cells treated with irons ions. Free Rad Biol Med. 1995;18(6):1013–1022
   PubMed Web of Science ®Google Scholar
• Kolnagou A, Economides C, Eracleous E, Kontoghiorghes GJ. Long term comparative studies in thalassemia patients treated with deferoxamine or a deferoxamine/deferiprone combination. Identification of effective chelation therapy protocols. Hemoglobin. 2008;32(1–2):41–47
   PubMed Web of Science ®Google Scholar
• Hubel CA, Kagan VE, Kisin ER, et al. Increased ascorbate radical formation and ascorbate depletion in plasma from women with preeclampsia: Implications for oxidative stress. Free Radic Biol Med. 1997;23(4):597–609
   PubMed Web of Science ®Google Scholar
• Kassab-Chekir A, Laradi S, Ferchichi S, et al. Oxidant, antioxidant status and metabolic data in patients with β-thalassemia. Clin Chim Acta. 2003;338(1–2):79–86
   PubMed Web of Science ®Google Scholar
• Chakraborty D, Bhattacharyya M. Antioxidant defense status of red blood cells of patients with β-thalassemia and E β-thalassemia. Clinica Chimica Acta. 2001;305(1–2):123–129
   PubMed Web of Science ®Google Scholar
• Dhawan V, Kumar KR, Marwaha RK, Ganguly NK. Antioxidant status in children with homozygous β-thalassemia. Indian Pediatr. 2005;42(11):1141–1145
   PubMed Web of Science ®Google Scholar
• Tesoriere L, D’Arpa D, Maggio A, et al. Oxidation resistance of LDL is correlated with vitamin E status in β thalassemia intermedia. Atherosclerosis. 1998;137(2):429–435
   PubMed Web of Science ®Google Scholar
• Miniero R, Canducci E, Ghigo D, et al. Vitamin E in β-thalassemia. Acta Vitaminol Enzymol. 1982;4(1–2):21–25
   PubMedGoogle Scholar
• Faintuch J, Aguilar PB, Nadalin W. Relevance of N-acetylcysteine in clinical practice: Fact, myth or consequence? Nutrition. 1999;15(2):177–179
   PubMed Web of Science ®Google Scholar
• Rachmilewitz EA, Weizer-Stern O, Adamsky K, et al. Role of iron in inducing oxidative stress in thalassemia: Can it be prevented by inhibition of absorption and by antioxidants? Ann N Y Acad Sci. 2005;1054:118–123
   PubMed Web of Science ®Google Scholar
• Duthie SJ, Ma A, Ross MA, Collins AR. Antioxidant supplementation decreases oxidative DNA damage in human lymphocytes. Cancer Res. 1996;15;56(6):1291–1295
   Web of Science ®Google Scholar
• Erel O. A novel automated method to measure total antioxidant response against potent-free radical reactions. Clin Biochem. 2004;37(2):112–119
   PubMed Web of Science ®Google Scholar
• Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005;38(12):1103–1111
   PubMed Web of Science ®Google Scholar
• Harma M, Harma M, Erel O. Increased oxidative stress in patients with hydatidiform mole. Swiss Med Wkly. 2003;133(41–42):563–566
   PubMed Web of Science ®Google Scholar
• Faust F, Kassie F, Knasmüller S, et al. The use of the alkaline comet assay with lymphocytes in human biomonitoring studies. Mutat Res. 2004;566(3):209–229
   PubMed Web of Science ®Google Scholar
• Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res. 1988;175(1):184–191
   PubMed Web of Science ®Google Scholar
• Minnet C, Koc A, Aycicek A, Kocyigit A. Vitamin B12 treatment reduces mononuclear DNA damage. Pediatr Int. 2011;53(6):1023–1027
   PubMed Web of Science ®Google Scholar
• Kocyigit A, Keles H, Selek S, et al. Increased DNA damage and oxidative stress in patients with cutaneous leishmaniasis. Mutat Res. 2005;585(1–2):71–78
   PubMed Web of Science ®Google Scholar
• Livrea MA, Tesoriere L, Pintaudi AM, et al. Oxidative stress and antioxidant status in β–thalassemia major: Iron overload and depletion of lipid soluble antioxidants. Blood. 1996;88(9):3608–3614
   PubMed Web of Science ®Google Scholar
• Amer J, Atlas D, Fibach E. N-acetylcysteine amide (AD4) attenuates oxidative stress in β-thalassemia blood cells. Biochim Biophys Acta. 2008;1780(2):249–255
   PubMed Web of Science ®Google Scholar
• Naithani R, Chandra J, Bhattacharjee J, et al. Peroxidative stress and antioxidant enzymes in children with β-thalassemia major. Pediatr Blood Cancer. 2006;46(7):780–785
   PubMed Web of Science ®Google Scholar
• Pavlova LE, Savov VM, Petkov HG, Charova IP. Oxidative stress in patients with β-thalassemia major. Prilozi. 2007;28(1):145–154
   PubMedGoogle Scholar
• Ghone RA, Kumbar KM, Suryakar AN, et al. Oxidative stress and disturbance in antioxidant balance in β thalassemia major. Indian J Clin Biochem. 2008;23(4):337–340
   PubMedGoogle Scholar
• Dissayabutra T, Tosukhowong P, Seksan P. The benefits of vitamin C and vitamin E in children with β-thalassemia with high oxidative stress. J Med Assoc Thai. 2005;88(Suppl 4):317–320
   PubMedGoogle Scholar
• Tesoriere L, D’Arpa D, Butera D, et al. Oral supplements of vitamin E improve measures of oxidative stress in serum and reduce oxidative damage to LDL and erythrocytes in β thalassemia intermedia patients. Free Radic Res. 2001;34(5):529–540
   PubMed Web of Science ®Google Scholar
• Das N, Chowdhury TD, Chattopadhyay A, Data AG. Attenuation of oxidative stress-induced changes in thalassemic erythrocytes by vitamin E. Pol J Pharmacol. 2004;56(1):85–96
   PubMedGoogle Scholar
• Suthutvoraut U, Hathirat P, Sasanakul W, et al. Vitamin E status, glutathione peroxidase activity and the effect of vitamin E supplementation in children with thalassemia. J Med Assoc Thai. 1993;76(suppl 2):146–152
   Google Scholar
• Pfeifer WP, Deqasperi GR, Almadia MT, et al. Vitamin E supplementation reduces oxidative stress in β thalassemia intermedia. Acta Haematol. 2008;120(4):225–231
   PubMed Web of Science ®Google Scholar
• Cheng M, Ho H, Tseng H, et al. Antioxidant deficit and enhanced susceptibility to oxidative damage in individuals with different forms of β-thalassaemia. Br J Haematol. 2005;128(1):119–127
   PubMed Web of Science ®Google Scholar
• Amer J, Goldfarb A, Fibach E. Flow cytometric analysis of the oxidative status of normal and thalassemic red blood cells. Cytometry. 2004;60(1):73–80
   PubMedGoogle Scholar
• Shires TK. Iron-induced DNA damage and synthesis in isolated rat liver nuclei. Biochem J. 1982;205(2):321–329
   PubMed Web of Science ®Google Scholar
• Mello Filho AC, Meneghini R. In vivo formation of single strand breaks in DNA by hydrogen peroxide is mediated by the Haber-Weiss reaction. Biochim Biophys Acta. 1984;781(1):56–63
   PubMed Web of Science ®Google Scholar
• Halliwell B, Gutteridge JMC. Role of free radicals and catalytic metal ions in human disease: An overview. Methods Enzymol. 1990;186:1–85
   PubMed Web of Science ®Google Scholar
• Flora S, Izzotti A, Agostini F, Balansky RM. Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking related end-points. Carcinogenesis. 2001;22(7):999–1013
   PubMed Web of Science ®Google Scholar
• Schulz KF, Grimes DA. Blinding in randomised trials: Hiding who got what. Lancet. 2002;359(9307):696–700
   PubMed Web of Science ®Google Scholar
• Moher D, Dulberg CS, Wells GA. Statistical power, sample size, and their reporting in randomized controlled trials. JAMA. 1994;272(2):122–124
   PubMed Web of Science ®Google Scholar